Mahmoud Khalil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahmoud Khalil has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Maraey
Department of Cardiology University of Toledo Medical Center Toledo Ohio USA
11 shared publications- Ahmed Elzanaty
University of Toledo, Toledo, OH
8 shared publications Ahmed M. Elzanaty
Cardiology Department, University of Toledo, Toledo, Ohio
6 shared publicationsAyman Saeyeldin
Internal Medicine Department, Saint Mary Hospital, Waterbury, USA
6 shared publicationsKenneth Ong
Cardiovascular Medicine Department, Lincoln Medical and Mental Health Center, New York City, USA
6 shared publicationsMohamed Shokr
Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University School of Medicine, New York City, USA
6 shared publications
Latest Publications
- 27 August 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 104 (5) , 928-933
Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample
Background: Chronic systemic anticoagulation use is prevalent for various thromboembolic conditions. Anticoagulation (usually through heparin products) is also recommended for the initial management of non‐ST‐elevation myocardial infarction (NSTEMI).Aims: To evaluate the in‐hospital outcomes of patients with NSTEMI who have been on chronic anticoagulation.Methods: Using the National Inpatient Sample (NIS) years 2016–2020, NSTEMI patients and patients with chronic anticoagulation were identified using the appropriate International Classification of Diseases, 10th version (ICD‐10) appropriate codes. The primary outcome was all‐cause in‐hospital mortality while the secondary outcomes included major bleeding, ischemic cerebrovascular accident (CVA), early percutaneous coronary intervention (PCI) (i.e., within 24 h of admission), coronary artery bypass graft (CABG) during hospitalization, length of stay (LOS), and total charges. Multivariate logistic or linear regression analyses were performed after adjusting for patient‐level and hospital‐level factors.Results: Among 2,251,914 adult patients with NSTEMI, 190,540 (8.5%) were on chronic anticoagulation. Chronic anticoagulation use was associated with a lower incidence of in‐hospital mortality (adjusted odds ratio [aOR]: 0.69, 95% confidence interval [CI]: 0.65−0.73, p < 0.001). There was no significant difference in major bleeding (aOR: 0.95, 95% CI: 0.88−1.0, p = 0.15) or ischemic CVA (aOR: 0.23, 95% CI: 0.03−1.69, p = 0.15). Chronic anticoagulation use was associated with a lower incidence of early PCI (aOR: 0.78, 95% CI: 0.76−0.80, p < 0.001) and CABG (aOR: 0.43, 95% CI: 0.41−0.45, p < 0.001). Chronic anticoagulation was also associated with decreased LOS and total charges (adjusted mean difference [aMD]: −0.8 days, 95% CI: −0.86 to −0.75, p < 0.001) and (aMD: $−19,340, 95% CI: −20,692 to −17,988, p < 0.001).Conclusions: Among patients admitted with NSTEMI, chronic anticoagulation use was associated with lower in‐hospital mortality, LOS, and total charges, with no difference in the incidence of major bleeding.
- 27 August 2024
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 104 (5) , 928-933
Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample
Background: Chronic systemic anticoagulation use is prevalent for various thromboembolic conditions. Anticoagulation (usually through heparin products) is also recommended for the initial management of non‐ST‐elevation myocardial infarction (NSTEMI).Aims: To evaluate the in‐hospital outcomes of patients with NSTEMI who have been on chronic anticoagulation.Methods: Using the National Inpatient Sample (NIS) years 2016–2020, NSTEMI patients and patients with chronic anticoagulation were identified using the appropriate International Classification of Diseases, 10th version (ICD‐10) appropriate codes. The primary outcome was all‐cause in‐hospital mortality while the secondary outcomes included major bleeding, ischemic cerebrovascular accident (CVA), early percutaneous coronary intervention (PCI) (i.e., within 24 h of admission), coronary artery bypass graft (CABG) during hospitalization, length of stay (LOS), and total charges. Multivariate logistic or linear regression analyses were performed after adjusting for patient‐level and hospital‐level factors.Results: Among 2,251,914 adult patients with NSTEMI, 190,540 (8.5%) were on chronic anticoagulation. Chronic anticoagulation use was associated with a lower incidence of in‐hospital mortality (adjusted odds ratio [aOR]: 0.69, 95% confidence interval [CI]: 0.65−0.73, p < 0.001). There was no significant difference in major bleeding (aOR: 0.95, 95% CI: 0.88−1.0, p = 0.15) or ischemic CVA (aOR: 0.23, 95% CI: 0.03−1.69, p = 0.15). Chronic anticoagulation use was associated with a lower incidence of early PCI (aOR: 0.78, 95% CI: 0.76−0.80, p < 0.001) and CABG (aOR: 0.43, 95% CI: 0.41−0.45, p < 0.001). Chronic anticoagulation was also associated with decreased LOS and total charges (adjusted mean difference [aMD]: −0.8 days, 95% CI: −0.86 to −0.75, p < 0.001) and (aMD: $−19,340, 95% CI: −20,692 to −17,988, p < 0.001).Conclusions: Among patients admitted with NSTEMI, chronic anticoagulation use was associated with lower in‐hospital mortality, LOS, and total charges, with no difference in the incidence of major bleeding.
- 13 September 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 206, 200-201
Use of a Multidisciplinary Shock Team and Inhospital Mortality in Patients With Cardiogenic Shock
- 13 September 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 206, 200-201
Use of a Multidisciplinary Shock Team and Inhospital Mortality in Patients With Cardiogenic Shock
- Open Access
- 3 April 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 68 (9) , 1947
Correction to: Outcomes of conventional pacemaker implantation in patients with dementia: insights from the National Readmission Database
- 3 April 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 68 (9) , 1947
Open AccessCorrection to: Outcomes of conventional pacemaker implantation in patients with dementia: insights from the National Readmission Database
- Open Access
- 3 April 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 68 (9) , 1945
Correction: Impact of chronic kidney disease on in-hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: Insights from the national readmission database
- 3 April 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 68 (9) , 1945
Open AccessCorrection: Impact of chronic kidney disease on in-hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: Insights from the national readmission database
- 29 November 2022
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 66 (6) , 1375-1382
Sex differences in outcomes of transvenous lead extraction: insights from National Readmission Database
Background With the growing use of implantable cardiac devices, the need for transvenous lead extraction has increased, which translates to increased procedural volumes. Sex differences in lead extraction outcomes are not well studied. Objective The present study aims at evaluating the impact of sex on outcomes of lead extraction. Methods We identified 71,754 patients who presented between 2016 and 2019 and underwent transvenous lead extraction. Their clinical data were retrospectively accrued from the National Readmission Database (NRD) using the corresponding diagnosis codes. We compared clinical outcomes between male and female patients. Odds ratios (ORs) for the primary and secondary outcomes were calculated, and multivariable regression analysis was utilized to adjust for confounding variables. Results Compared to male patients, female patients had higher in-hospital complications including pneumothorax (OR 1.26, 95% CI (1.07–1.4), P < 0.01), hemopericardium (OR 1.39, 95% CI (1.02–1.88), P = 0.036), injury to superior vena cava and innominate vein requiring repair (OR 1.88, 95% CI (1.14–3.1), P = 0.014; OR 3.4, 95% CI (1.8–6.5), P < 0.01), need for blood transfusion (OR 1.28, 95% CI (1.18–1.38), P < 0.01), and pericardiocentesis (OR 1.6, 95% CI (1.3–2), P < 0.01). Thirty-day readmission was also significantly higher in female patients (OR 1.09, 95% CI (1.02–1.17), P < 0.01). There was no significant difference regarding in-hospital mortality (OR 0.99, 95% CI (0.87–1.14), P = 0.95). Conclusion In female patients, lead extraction is associated with worse clinical outcomes and higher 30-day readmission rate.
- 29 November 2022
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 66 (6) , 1375-1382
Sex differences in outcomes of transvenous lead extraction: insights from National Readmission Database
Background With the growing use of implantable cardiac devices, the need for transvenous lead extraction has increased, which translates to increased procedural volumes. Sex differences in lead extraction outcomes are not well studied. Objective The present study aims at evaluating the impact of sex on outcomes of lead extraction. Methods We identified 71,754 patients who presented between 2016 and 2019 and underwent transvenous lead extraction. Their clinical data were retrospectively accrued from the National Readmission Database (NRD) using the corresponding diagnosis codes. We compared clinical outcomes between male and female patients. Odds ratios (ORs) for the primary and secondary outcomes were calculated, and multivariable regression analysis was utilized to adjust for confounding variables. Results Compared to male patients, female patients had higher in-hospital complications including pneumothorax (OR 1.26, 95% CI (1.07–1.4), P < 0.01), hemopericardium (OR 1.39, 95% CI (1.02–1.88), P = 0.036), injury to superior vena cava and innominate vein requiring repair (OR 1.88, 95% CI (1.14–3.1), P = 0.014; OR 3.4, 95% CI (1.8–6.5), P < 0.01), need for blood transfusion (OR 1.28, 95% CI (1.18–1.38), P < 0.01), and pericardiocentesis (OR 1.6, 95% CI (1.3–2), P < 0.01). Thirty-day readmission was also significantly higher in female patients (OR 1.09, 95% CI (1.02–1.17), P < 0.01). There was no significant difference regarding in-hospital mortality (OR 0.99, 95% CI (0.87–1.14), P = 0.95). Conclusion In female patients, lead extraction is associated with worse clinical outcomes and higher 30-day readmission rate.
- 7 November 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 186, 80-86
Outcomes of Coronary Artery Bypass Grafting in Patients With Previous Mediastinal Radiation
- 7 November 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 186, 80-86
Outcomes of Coronary Artery Bypass Grafting in Patients With Previous Mediastinal Radiation
- 5 November 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 186, 66-70
Meta-Analysis on Invasive Versus Conservative Strategy in Patients Older Than Seventy Years With Non-ST Elevation Myocardial Infarction
- 5 November 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 186, 66-70
Meta-Analysis on Invasive Versus Conservative Strategy in Patients Older Than Seventy Years With Non-ST Elevation Myocardial Infarction
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 117-118
Temporal Trends and Safety Outcomes Associated With Suction Thrombectomy of Right-Sided Intra-Cardiac Thrombus
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 117-118
Temporal Trends and Safety Outcomes Associated With Suction Thrombectomy of Right-Sided Intra-Cardiac Thrombus
- 27 June 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 100 (2) , 245-253
Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation
Objective: To examine the rate of readmission for permanent pacemaker (PPM) implantation with early versus late discharge after transcatheter aortic valve replacement (TAVR).Background: There is a current trend toward early discharge after TAVR. However, paucity of data exists on the impact of such practice on readmissions for PPM implantation.Methods: The Nationwide Readmission Database 2016–2018 was queried for all hospitalizations where patients underwent TAVR. Hospitalizations were stratified into early (Days 0 and 1) versus late (≥Day 2) discharge groups. Observations in which PPM was required in the index admission were excluded. Multivariable regression analyses involving patient‐ and hospital‐related variables were utilized. The primary outcome was 90‐day readmission for PPM implantation.Results: The final analysis included 68,482 TAVR hospitalizations, 20,261 (29.6%) with early versus 48,221 (70.4%) with late discharge. Early discharge after TAVR increased over the study period (16.2% in 2016 vs. 37.9% in 2018, Ptrend < 0.01). Nevertheless, 90‐day readmission for PPM implantation remained stable (1.8% in 2016 vs. 2.0% in 2018, Ptrend = 0.32). The 90‐day readmission rate for PPM implantation (2.0% vs. 1.8%; adjusted odds ratio: 1.15; 95% confidence interval: 0.95–1.39; p = 0.15) and median time‐to‐readmission (5 days [interquartile range, IQR 3–9] vs. 5 days [IQR 3–14], p = 0.92) were similar with early versus late discharge. Similar rates were observed regardless of whether readmission was elective versus not. Early discharge was associated with lower hospitalization cost ($39,990 ± $13,681 vs. $46,750 ± $18,218, p < 0.01) compared with late discharge.Conclusion: In patients who did not require PPM during the index TAVR hospitalization, the rate of readmission for PPM implantation was similar with early versus late discharge.
- 27 June 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 100 (2) , 245-253
Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation
Objective: To examine the rate of readmission for permanent pacemaker (PPM) implantation with early versus late discharge after transcatheter aortic valve replacement (TAVR).Background: There is a current trend toward early discharge after TAVR. However, paucity of data exists on the impact of such practice on readmissions for PPM implantation.Methods: The Nationwide Readmission Database 2016–2018 was queried for all hospitalizations where patients underwent TAVR. Hospitalizations were stratified into early (Days 0 and 1) versus late (≥Day 2) discharge groups. Observations in which PPM was required in the index admission were excluded. Multivariable regression analyses involving patient‐ and hospital‐related variables were utilized. The primary outcome was 90‐day readmission for PPM implantation.Results: The final analysis included 68,482 TAVR hospitalizations, 20,261 (29.6%) with early versus 48,221 (70.4%) with late discharge. Early discharge after TAVR increased over the study period (16.2% in 2016 vs. 37.9% in 2018, Ptrend < 0.01). Nevertheless, 90‐day readmission for PPM implantation remained stable (1.8% in 2016 vs. 2.0% in 2018, Ptrend = 0.32). The 90‐day readmission rate for PPM implantation (2.0% vs. 1.8%; adjusted odds ratio: 1.15; 95% confidence interval: 0.95–1.39; p = 0.15) and median time‐to‐readmission (5 days [interquartile range, IQR 3–9] vs. 5 days [IQR 3–14], p = 0.92) were similar with early versus late discharge. Similar rates were observed regardless of whether readmission was elective versus not. Early discharge was associated with lower hospitalization cost ($39,990 ± $13,681 vs. $46,750 ± $18,218, p < 0.01) compared with late discharge.Conclusion: In patients who did not require PPM during the index TAVR hospitalization, the rate of readmission for PPM implantation was similar with early versus late discharge.